Physician profile
Cori C Wirth
NPI 1275121675
$1,405.40
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,071 · 2023: $222 · 2024: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $334.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $230.62 | 2022 | |
| Ucb, INC. | $159.95 | 2022-2023 | Briviact |
| Genzyme Corporation | $117.16 | 2022-2023 | |
| Abbvie INC. | $83.39 | 2022-2024 | |
| Indivior INC. | $66.32 | 2023-2024 | Sublocade |
| Sunovion Pharmaceuticals INC. | $57.15 | 2022 | |
| Lilly USA, LLC | $53.68 | 2022-2023 | Reyvow, Emgality |
| Novartis Pharmaceuticals Corporation | $50.91 | 2022-2023 | |
| Biogen, INC. | $49.74 | 2022 | |
| Genentech USA, INC. | $49.01 | 2022 | |
| Celgene Corporation | $44.12 | 2022 | |
| Amgen INC. | $40.29 | 2022 | |
| Emd Serono, INC. | $35.96 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $35.69 | 2022 | |
| Sk Life Science, INC. | $35.17 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $34.34 | 2023 | Lucemyra |
| Braeburn INC. | $32.53 | 2023-2024 | Brixadi |
| Medtronic, INC. | $32.52 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $30.09 | 2022 | |
| Neurocrine Biosciences, INC. | $28.25 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $22.65 | 2024 | Rexulti |
| Tanabe Pharma America, INC. | $22.23 | 2022 | |
| Alkermes, INC. | $21.73 | 2024 | Vivitrol |
| Alnylam Pharmaceuticals INC. | $20.70 | 2022 | |
| Avion Pharmaceuticals | $18.05 | 2023 | Dhivy |
| Orexo US, INC. | $17.06 | 2023 | Zubsolv |
| Jazz Pharmaceuticals INC. | $16.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cori Wirth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.